Aeon Biopharma, INC. (AEON) — 10-K/A Filings

All 10-K/A filings from Aeon Biopharma, INC.. Browse 3 Amended Annual Report reports with AI-powered summaries and risk analysis.

10-K/A Filings (3)

AEON Biopharma Amends 2024 10-K, Maintains Emerging Growth Status — Jun 11, 2025 Risk: medium
AEON Biopharma, Inc. filed a 10-K/A on June 11, 2025, for the fiscal year ended December 31, 2024, primarily to amend its annual report. As a clinical-stage bio
AEON Biopharma Files 2023 10-K Amendment — Aug 12, 2024 Risk: low
AEON Biopharma, Inc. filed an amendment (Amendment No. 2) to its annual report on Form 10-K for the fiscal year ended December 31, 2023. The filing, dated Augus
AEON Biopharma, Inc. Files Amended 10-K for Fiscal Year Ended December 31, 2023 — May 14, 2024 Risk: medium
AEON Biopharma, Inc. (AEON) filed a Amended Annual Report (10-K/A) with the SEC on May 14, 2024. AEON Biopharma, Inc. filed an amended 10-K for the fiscal year

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX